CollPlant Biotechnologies Ltd SEC filings CLGN

CollPlant Biotechnologies Ltd has 356 filings in SEC EDGAR's recent list, going back to Feb 20, 2015. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Mar 26, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Mar 26, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Apr 4, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Mar 29, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 24, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 26, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Apr 1, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Apr 1, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 20, 2018 Dec 31, 2017

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
CLGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Rehovot, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1631487
Former names
CollPlant Biotechnologies Ltd. (until Jun 20, 2019); CollPlant Holdings Ltd. (until Jun 6, 2019)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.